Anthem Inc (NYSE:ANTM) shares gapped up before the market opened on Friday after Morgan Stanley raised their price target on the stock from $359.00 to $371.00. The stock had previously closed at $311.15, but opened at $303.88. Morgan Stanley currently has an overweight rating on the stock. Anthem shares last traded at $309.60, with a volume of 98,135 shares changing hands.
Several other brokerages also recently weighed in on ANTM. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 price target on shares of Emergent Biosolutions in a research report on Sunday, April 21st. SunTrust Banks reissued a “hold” rating and set a $44.00 price target on shares of Shutterstock in a research report on Thursday, April 25th. Zacks Investment Research downgraded shares of G1 Therapeutics from a “buy” rating to a “hold” rating in a research report on Thursday, May 16th. Citigroup reissued a “buy” rating on shares of Healthequity in a research report on Friday, May 10th. Finally, Barclays raised their price target on shares of T. Rowe Price Group from $90.00 to $95.00 and gave the company an “underweight” rating in a research report on Thursday, April 25th. Two research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Anthem presently has a consensus rating of “Buy” and a consensus target price of $325.67.
In other Anthem news, SVP Ronald W. Penczek sold 763 shares of Anthem stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $279.00, for a total value of $212,877.00. Following the completion of the sale, the senior vice president now owns 2,295 shares of the company’s stock, valued at approximately $640,305. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Thomas C. Zielinski sold 8,826 shares of Anthem stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $283.92, for a total transaction of $2,505,877.92. Following the completion of the sale, the executive vice president now directly owns 33,183 shares of the company’s stock, valued at approximately $9,421,317.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,245 shares of company stock valued at $3,174,155. 0.17% of the stock is currently owned by insiders.
A number of large investors have recently bought and sold shares of the business. Clark Capital Management Group Inc. purchased a new position in shares of Anthem during the 2nd quarter worth $19,463,000. CENTRAL TRUST Co boosted its stake in shares of Anthem by 3.3% during the 2nd quarter. CENTRAL TRUST Co now owns 2,891 shares of the company’s stock worth $879,000 after acquiring an additional 91 shares during the last quarter. Community Bank & Trust Waco Texas boosted its stake in shares of Anthem by 2.1% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 14,901 shares of the company’s stock worth $4,205,000 after acquiring an additional 301 shares during the last quarter. Diversified Trust Co boosted its stake in shares of Anthem by 6.3% during the 2nd quarter. Diversified Trust Co now owns 1,014 shares of the company’s stock worth $286,000 after acquiring an additional 60 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. boosted its stake in shares of Anthem by 252.0% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 523,468 shares of the company’s stock worth $147,728,000 after acquiring an additional 374,746 shares during the last quarter. 87.11% of the stock is owned by institutional investors and hedge funds.
The firm has a 50 day simple moving average of $283.36. The firm has a market cap of $78.16 billion, a price-to-earnings ratio of 19.54, a PEG ratio of 1.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.61 and a current ratio of 1.61.
Anthem (NYSE:ANTM) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $6.03 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $5.86 by $0.17. The business had revenue of $24.39 billion for the quarter, compared to analysts’ expectations of $24.31 billion. Anthem had a net margin of 4.23% and a return on equity of 14.99%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $5.41 EPS. On average, equities analysts anticipate that Anthem Inc will post 19.26 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th were paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Friday, June 7th. Anthem’s dividend payout ratio is presently 20.14%.
Anthem Company Profile (NYSE:ANTM)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: How is the Producer Price Index calculated?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.